EDRS
REGN icon

Edmond de Rothschild (Suisse)’s Regeneron Pharmaceuticals REGN Stock Holding History

Edmond de Rothschild (Suisse)’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$322K Hold
800
– – 0.1% 172
2016
Q2 		$279K Buy
800
+400
+100% +$154K 0.09% 160
2016
Q1 		$144K Buy
+400
New +$165K 0.06% 169

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Edmond de Rothschild (Suisse)'s REGN Position: Q3 2016 in Review

Edmond de Rothschild (Suisse) held its Regeneron Pharmaceuticals (REGN) position steady in Q3 2016 at 800 shares worth $322K. The position accounts for 0.1% of the portfolio, ranked #172.

Edmond de Rothschild (Suisse) first reported a position in REGN in Q1 2016 and has held it in 3 quarters since. 555 funds tracked by Wall St. Rank hold REGN as of Q3 2016.

  • Edmond de Rothschild (Suisse) held 800 shares of Regeneron Pharmaceuticals worth $322K as of Q3 2016.
  • Edmond de Rothschild (Suisse) left its Regeneron Pharmaceuticals share count unchanged in Q3 2016.
  • Regeneron Pharmaceuticals made up 0.1% of Edmond de Rothschild (Suisse)'s portfolio in Q3 2016, its #172 holding.
  • Edmond de Rothschild (Suisse) first reported a position in Regeneron Pharmaceuticals in Q1 2016 and has held it in 3 quarters since.
  • 555 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2016.

Based on Edmond de Rothschild (Suisse)'s 13F filing for Q3 2016, filed 14 Nov 2016.